141 related articles for article (PubMed ID: 3909331)
1. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
[TBL] [Abstract][Full Text] [Related]
2. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
Birolini D; Moraes MF; de Souza OS
Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam plus clindamycin versus tobramycin plus clindamycin in the treatment of intraabdominal infections.
Williams RR; Hotchkin D
Rev Infect Dis; 1991; 13 Suppl 7():S629-33. PubMed ID: 2068472
[TBL] [Abstract][Full Text] [Related]
4. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
5. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli.
Nolen TM; Phillips HL; Hall HJ
Rev Infect Dis; 1985; 7 Suppl 4():S666-8. PubMed ID: 3909321
[TBL] [Abstract][Full Text] [Related]
6. Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections.
Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S703-8. PubMed ID: 3909327
[TBL] [Abstract][Full Text] [Related]
7. Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections.
Swabb EA; Cone CO; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S675-8. PubMed ID: 3909323
[TBL] [Abstract][Full Text] [Related]
8. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
Barboza E; del Castillo M; Yi A; Gotuzzo E
Surgery; 1994 Jul; 116(1):28-35. PubMed ID: 8023265
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam in treatment of intra-abdominal infections.
Malangoni MA
Urology; 1988 Jun; 31(6 Suppl):28-32. PubMed ID: 3287747
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with aztreonam.
Stutman HR
Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S109-12; discussion S128-32. PubMed ID: 2682508
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections.
Harding GK; Nicolle LE; Haase DA; Aoki FY; Stiver HG; Blanchard RJ; Kirkpatrick JR
Rev Infect Dis; 1984; 6 Suppl 1():S283-92. PubMed ID: 6326244
[TBL] [Abstract][Full Text] [Related]
13. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with aztreonam in Germany and Austria.
Stille W; Gillissen J
Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
[TBL] [Abstract][Full Text] [Related]
15. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
Swabb EA; Jenkins SA; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
Simons WJ; Lee TJ
Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
[TBL] [Abstract][Full Text] [Related]
18. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
19. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
20. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
